Literature DB >> 22365426

Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.

Martin Adiels1, Niina Matikainen, Jukka Westerbacka, Sanni Söderlund, Thomas Larsson, Sven-Olof Olofsson, Jan Borén, Marja-Riitta Taskinen.   

Abstract

OBJECTIVE: To better understand the postprandial clearance of triglyceride-rich lipoproteins (TRLs) and its relation to the fasting kinetics of TRLs.
METHODS: Two studies were performed on 30 male subjects: a fasting kinetic study to determine the fasting secretion and clearance rates of apolipoprotein B (apoB) 100 and triglycerides in the very low-density lipoprotein 1 and 2 (VLDL(1) and VLDL(2)) fractions; and a postprandial study to determine the postprandial accumulation of apoB48, apoB100 and triglycerides in the chylomicron, VLDL(1) and VLDL(2) fractions. Results from these two studies were combined to characterize the postprandial clearance of TRLs in a physiologically relevant setting.
RESULTS: Our results show that postprandial accumulation of the apoB48-carrying chylomicrons can be predicted from the clearance capacity of the lipolytic pathway, determined in the fasting state. Furthermore, we show that chylomicrons and VLDL(1) particles are not cleared equally by the lipoprotein lipase pathway, and that chylomicrons seem to be the preferred substrate. Subjects with a rapid fasting lipid metabolism accumulate lower levels of postprandial triglycerides with less accumulation of apoB100 in the VLDL(1) fraction and a faster transfer of apoB100 into the VLDL(2) fraction. In contrast, fasting VLDL(1) secretion does not predict postprandial triglyceride accumulation.
CONCLUSIONS: Non-fasting triglyceride levels have recently been identified as a major predictor of future cardiovascular events. Here we show that the capacity of the lipolytic pathway is a common determinant of both the fasting and non-fasting triglyceride levels and may thus play an important role in the development of dyslipemia and atherosclerosis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365426     DOI: 10.1016/j.atherosclerosis.2012.02.001

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  21 in total

1.  Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36.

Authors:  Latisha Love-Gregory; Aldi T Kraja; Fiona Allum; Stella Aslibekyan; Åsa K Hedman; Yanan Duan; Ingrid B Borecki; Donna K Arnett; Mark I McCarthy; Panos Deloukas; Jose M Ordovas; Paul N Hopkins; Elin Grundberg; Nada A Abumrad
Journal:  J Lipid Res       Date:  2016-10-11       Impact factor: 5.922

2.  TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.

Authors:  Elizabeth A O'Hare; Rongze Yang; Laura M Yerges-Armstrong; Urmila Sreenivasan; Rebecca McFarland; Carmen C Leitch; Meredith H Wilson; Shilpa Narina; Alexis Gorden; Kathy A Ryan; Alan R Shuldiner; Steve A Farber; G Craig Wood; Christopher D Still; Glenn S Gerhard; Janet D Robishaw; Carole Sztalryd; Norann A Zaghloul
Journal:  Hepatology       Date:  2017-03-22       Impact factor: 17.425

Review 3.  The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia.

Authors:  Peter Novodvorský; Martin Haluzík
Journal:  Curr Atheroscler Rep       Date:  2022-01-24       Impact factor: 5.113

4.  Metabolism of Triglyceride-Rich Lipoproteins.

Authors:  Jan Borén; Marja-Riitta Taskinen
Journal:  Handb Exp Pharmacol       Date:  2022

Review 5.  Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.

Authors:  Bai-Hui Zhang; Fan Yin; Ya-Nan Qiao; Shou-Dong Guo
Journal:  Front Mol Biosci       Date:  2022-05-25

Review 6.  Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia.

Authors:  Jan Borén; Marja-Riitta Taskinen; Elias Björnson; Chris J Packard
Journal:  Nat Rev Cardiol       Date:  2022-03-22       Impact factor: 49.421

7.  Lipidomic profiling of chylomicron triacylglycerols in response to high fat meals.

Authors:  Maxine P Bonham; Kaisa M Linderborg; Aimee Dordevic; Amy E Larsen; Kay Nguo; Jacquelyn M Weir; Petra Gran; Marika K Luotonen; Peter J Meikle; David Cameron-Smith; Heikki P T Kallio; Andrew J Sinclair
Journal:  Lipids       Date:  2012-11-03       Impact factor: 1.880

8.  Measuring short-term liver metabolism non-invasively: postprandial and post-exercise ¹H and ³¹P MR spectroscopy.

Authors:  Antti Hakkarainen; Jesper Lundbom; Esa K Tuominen; Marja-Riitta Taskinen; Kirsi H Pietiläinen; Nina Lundbom
Journal:  MAGMA       Date:  2014-06-04       Impact factor: 2.310

9.  Triglyceride Paradox Is Related to Lipoprotein Size, Visceral Adiposity and Stearoyl-CoA Desaturase Activity in Black Versus White Women.

Authors:  Stephanie T Chung; Celeste K L Cravalho; Abby G Meyers; Amber B Courville; Shanna Yang; Nirupa Rachel Matthan; Lilian Mabundo; Maureen Sampson; Ronald Ouwerkerk; Ahmed M Gharib; Alice H Lichtenstein; Alan T Remaley; Anne E Sumner
Journal:  Circ Res       Date:  2019-10-18       Impact factor: 17.367

Review 10.  Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.

Authors:  Aleesha Shaik; Robert S Rosenson
Journal:  Cardiovasc Drugs Ther       Date:  2021-03-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.